Fluticasone propion
Ended Awarded Last action
- Contract number
- SPE2DP26F1140
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $27,268
Award facts
- Contract value 100% obligated
- $27,268.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $27,268.02 on December 10, 2025, for the supply of fluticasone propionate. This firm fixed-price delivery order, with an ultimate completion date of December 26, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a specific product purchase under DMS Pharmaceutical Group's broader prime vendor contract with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply to Department of Defense healthcare facilities. The parent contract, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional supplier for military medical operations. The company's extensive product portfolio encompasses branded and generic pharmaceuticals, biologics, vaccines, specialty medications, and medical consumables, enabling it to fulfill diverse pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DP26F1140?
SPE2DP26F1140 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 10, 2025.
How much is contract SPE2DP26F1140 worth?
The government has obligated $27,268 on SPE2DP26F1140.
Is contract SPE2DP26F1140 an order under another contract?
Yes. SPE2DP26F1140 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F1140 competed?
The extent of competition for SPE2DP26F1140 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award